Clinical trials: Aspiration Pneumonia

COVID-19

Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine

• Unknown status
• Age: 21 to 65 years
• Phase 1
• Vaccines

In this trial, a single-arm, open-label study design will be used to evaluate the safety and tolerability after vaccination with escalating doses of the investigational vaccine (Recombinant COVID-19 Vaccine (chimpanzee adenovirus…

Trial name

NCT05706324

Testing

Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation

Where

Singapore

Volunteers

60 people, healthy volunteers welcome

Sponsor

Wuhan BravoVax Co., Ltd.